Characteristics | Group | p-value | ||
---|---|---|---|---|
Thalassemia (Group 1A) 117 (54.2%) | Sickle cell anemia (Group 1B) 50 (23.1%) | IDA Group 2 49 (22.7%) | ||
Age at onset (year) | ||||
 Mean ± SD | 21.77 ± 13.31 | 27.3 ± 12.59 | 33.12 ± 9.35 | < 0.001* |
 Median (IQR) | 18 (13–30) | 26.5 (20–36.25) | 32 (25–39.5) |  |
Gender | ||||
 Male | 74 (63.2%) | 29 (58%) | 14 (28.6%) | < 0.001* |
 Female | 43 (36.8%) | 21 (42%) | 35 (71.4%) |  |
Governorate | ||||
 Assiut | 26 (22.2%) | 10 (20%) | 3 (6.1%) |  |
 Sohag | 67 (57.3%) | 31 (62%) | 41 (83.7%) |  |
 El Minia | 5 (4.3%) | 2 (4%) | 3 (6.1%) | 0.120 |
 Qena | 5 (4.3%) | 0 (0.0%) | 2 (4.1%) |  |
 Aswan | 4 (3.4%) | 2 (4%) | 0 (0.0%) |  |
 Red Sea | 5 (4.3%) | 3 (6%) | 0 (0.0%) |  |
 Luxor | 2 (1.7%) | 1 (2%) | 0 (0.0%) |  |
 New Valley | 3 (2.6%) | 1 (2%) | 0 (0.0%) |  |
Presentation | ||||
 Acute hemolysis | 47 (40.2%) | 11 (22%) | 0 (0.0%) |  |
 Painful crisis | 0 (0.0%) | 13 (26%) | 0 (0.0%) |  |
 Acute abdomen | 16 (13.7%) | 4 (8%) | 2 (4.1%) |  |
 Anemic symptoms | 34 (29.1%) | 7 (14%) | 30 (61.2%) | < 0.0001* |
 Huge splenomegaly | 3 (2.6%) | 0 (0.0%) | 0 (0.0%) |  |
 Jaundice | 15 (12.8%) | 2 (4%) | 0 (0.0%) |  |
 ACS | 0 (0.0%) | 2 (4%) | 0 (0.0%) |  |
 Obstructive jaundice | 2 (1.7%) | 11 (22%) | 2 (4.1%) |  |
 Chronic bleeding | 0 (0.0%) | 0 (0.0%) | 15 (30.6%) |  |
Transfusion dependency | Â | Â | Â | < 0.0001* |
 Dependent | 65 (55.6%) | 1 (2%) | 0 (0.0%) |  |
 Independent | 52 (44.4%) | 49 (98%) | 49 (100%) |  |